Literature DB >> 14997232

Infective endocarditis: improving the diagnostic yield.

C F N Koegelenberg1, A F Doubell, H Orth, H Reuter.   

Abstract

INTRODUCTION: Isolating aetiological agents in patients with infective endocarditis (IE) remains problematical. We postulated that the high local incidence of culture-negative IE resulted from antibiotic exposure prior to blood cultures and that a structured delay in therapy in the subacute presentation would improve the diagnostic yield. AIM: We aimed to prospectively observe the diagnostic approach and give an overview of supplementary laboratory tests. STUDY
DESIGN: Patients with suspected IE were enrolled into this analytical observational study and followed up for six months (n = 92). We compared the diagnostic yield and outcome in cases where antibiotics were withheld for 72 hours, with those cases who received early antimicrobials, despite being deemed safe for delayed therapy.
RESULTS: Definitive diagnoses (definite or excluded IE) were made in 92.8% of patients where antibiotics were delayed, compared to 60% of patients who received empirical treatment (p = 0.08). The mortality rates were 18.4% and 30.0% (p = 0.18). Twenty-three of 26 patients with definite culture-negative IE received antibiotics during the 48 hours preceding cultures, compared to eight of 21 culture-positive patients (P < 0.001). Screening for atypical bacteria did not improve the yield. C-reactive protein (CRP) had a sensitivity of 97.0% (negative predictive value 87.5%), whereas a positive rheumatoid factor (RF) had a specificity of 93.8% (positive predictive value 91.7%).
CONCLUSIONS: We observed tendencies towards a greater diagnostic yield and lower mortality where antibiotics were initially withheld. Antibiotic prior to blood cultures were an important cause of culture-negative IE. A normal CRP proved useful in excluding IE; a positive RF strongly favoured IE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997232

Source DB:  PubMed          Journal:  Cardiovasc J S Afr


  9 in total

Review 1.  Molecular methods for diagnosis of infective endocarditis.

Authors:  Gorm Lisby; Ernö Gutschik; David T Durack
Journal:  Infect Dis Clin North Am       Date:  2002-06       Impact factor: 5.982

2.  Molecular methods for diagnosis of infective endocarditis.

Authors:  Annette Moter; Michele Musci; Dinah Schmiedel
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

3.  16S-Ribosomal DNA to diagnose culture-negative endocarditis.

Authors:  Guillermo E Madico; Peter A Rice
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

Review 4.  Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa.

Authors:  Vuyisile T Nkomo
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

5.  Extension of antimicrobial treatment in patients with left-sided native valve endocarditis based on elevated C-reactive protein values.

Authors:  D W M Verhagen; J Hermanides; J C Korevaar; P M M Bossuyt; R B A van den Brink; P Speelman; J T M van der Meer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

6.  An echocardiographic study of infective endocarditis, with special reference to patients with HIV.

Authors:  S H Nel; D P Naidoo
Journal:  Cardiovasc J Afr       Date:  2014 Mar-Apr       Impact factor: 1.167

7.  Neutrophil-Lymphocyte Ratio in Predicting Infective Endocarditis: A Case-Control Retrospective Study.

Authors:  Ying Chen; Liang-Jun Ye; Yue Wu; Bing-Zheng Shen; Fan Zhang; Qiang Qu; Jian Qu
Journal:  Mediators Inflamm       Date:  2020-11-27       Impact factor: 4.711

8.  Assesment of the Duke criteria for the diagnosis of infective endocarditis after twenty-years. An analysis of 241 cases.

Authors:  Adriana Topan; Dumitru Carstina; Adriana Slavcovici; Raluca Rancea; Radu Capalneanu; Mihaela Lupse
Journal:  Clujul Med       Date:  2015-07-01

9.  Effect of prior receipt of antibiotics on the pathogen distribution: a retrospective observational cohort study on 27,792 patients.

Authors:  Leiqing Li; Lingcheng Xu; Rongsheng Zhu; Jiaojiao Song; Xuanding Wang
Journal:  BMC Infect Dis       Date:  2020-01-06       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.